← board
NBP
distress 5/10 · elevated risk$1.75+0%today-73% from 52w high
Revenue
pre-revenue
Liquidity
$211M
Runway
1.1 yrs
Shares 1y
0%
Price & events
-55.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.3%
1D
-2.5%
1W
+8.4%
1M
-29.4%
3M
-55.1%
6M
-17.3%
1Y
+22.0%
2Y
-97.6%
5Y
-96.1%
All
Overview
- Market Cap
- $463.08M
- Volume
- 195.79K
- 52 Week Range
- $1.47 – $6.56
- Total Shares
- 265.38M
- Float Shares
- 63.28M
- Short %
- 5.01%
- % Held by Insiders
- 14.41%
- % Held by Institutions
- 39.91%
- RVOL
- 0.31x
- Beta
- 1.45
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-07-28Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $8 (+358% upside) · 3 analysts
- 2026-04-08HC Wainwright & Co.Buy
- 2026-03-16HC Wainwright & Co.Buy
- 2026-02-06HC Wainwright & Co.Buy
- 2025-10-24BTIGBuy
- 2025-10-17BTIGBuy
- 2025-10-03Leerink PartnersOutperform
Competitors
- none identified
Recent news
- 2026-07-19NovaBridge Biosciences (NBP) Holds Near Support Amid Modest Pullback - Combination Correction - dars.gov.et
- 2026-07-19NovaBridge Biosciences (NBP) Holds Near Support as Modest Decline Continues - GEX Level - dars.gov.et
- 2026-07-17NovaBridge Biosciences Launches 2026 Omnibus Share Incentive Plan - TipRanks
- 2026-07-17NovaBridge Biosciences (NBP) sets 2026 equity plan with 11.96M shares - Stock Titan
- 2026-07-17NovaBridge Biosciences launches 2026 omnibus share incentive plan with 11,960,000 shares authorized - Bitget
- 2026-07-10NovaBridge Biosciences (NBP) Edges Higher With Technical Resistance in Sight - Zigzag Correction - dars.gov.et
- 2026-07-10NovaBridge Biosciences (NBP) awards 949,050 long-dated stock options to its CCO - Stock Titan
- 2026-07-10NovaBridge Biosciences (NBP) awards 254,780 employee share options to General Counsel - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.